Pharma's AI is missing the "Why”

Artificial intelligence (AI) is reshaping the pharmaceutical industry, driving advances from drug discovery and clinical trial acceleration to manufacturing optimisation and commercialisation. And it’s easy to see why – AI’s potential is staggering, with its adoption increasingly reflected in the KPIs of every major pharma company. But here’s the problem: for all the hype, many in the industry still don’t fully understand what AI is – or its capabilities.